BCAS2P2

Across TCGA pan-cancer cohorts, BCAS2P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated BCAS2P2 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher BCAS2P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BCAS2P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and UVM are the cancer types where BCAS2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.762	0.615	<.001	122	view →
SKCM	OS	Median	All	0.828	0.733	<.001	121	view →
UVM	OS	Tertile	III,IV	0.089	0.841	<.001	78	view →
LUAD	OS	Median	All	0.787	0.610	<.001	50	view →
CESC	DFS	Median	All	0.825	0.650	<.001	46	view →
OV	DFS	Quartile	All	0.428	0.302	.004	42	view →
UCS	OS	Quartile	All	0.301	0.717	<.001	30	view →
UCEC	OS	Quartile	All	0.969	0.903	.013	20	view →
LGG	OS	Median	All	0.325	0.568	<.001	18	view →
ACC	OS	Tertile	All	0.251	0.743	.008	12	view →
THCA	OS	Quartile	III,IV	0.906	1.000	.014	9	view →
SARC	OS	Quartile	All	0.914	0.794	.020	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

BCAS2P2–HNSC (DFS)

Open the HNSC breakdown →